Mark Identification

IDEATE IPILIMUMAB DRUG EVALUATION IMMUNOTHERAPY IN SQUAMOUS NSCLC

Serial Number

85595704

Filing Date

Apr 12, 2012

Registration Date

Feb 18, 2014

Trademark by

Classification Information

Product research and development; conducting clinical trials relating to pharmaceutical preparations for human use